Ultragenyx Pharmaceutical (RARE) Interest Expenses (2013 - 2014)
Ultragenyx Pharmaceutical (RARE) reported Interest Expenses of $73000.0 for Q2 2014, down 82.02% year-over-year from $406000.0 in Q2 2013, and down 97.84% quarter-over-quarter from $3.4 million in Q1 2014.
Ultragenyx Pharmaceutical (RARE) Interest Expenses (2013 - 2014) Analysis & Trends
Ultragenyx Pharmaceutical (RARE) has 2 years of Interest Expenses data on file, last reported at $73000.0 in Q2 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.77 Bn | 2.36 Bn | 106.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2014 | 73,000.00 |
| Jun 30, 2014 | 73,000.00 |
| Mar 31, 2014 | 3.38 Mn |
| Mar 31, 2014 | 3.38 Mn |
| Jun 30, 2013 | 406,000.00 |
| Jun 30, 2013 | 406,000.00 |
| Mar 31, 2013 | 14,000.00 |
| Mar 31, 2013 | 14,000.00 |